Diseases of the vascular system result from a complex mixture of genetic an
d environmental factors. Data sets, technologies and strategies emanating f
rom the human genome programme have been applied to the analysis of both ra
re single-gene and common multigenic vascular disorders. Genomic approaches
including inter- and intraspecies sequence comparisons, genotyping with de
nse marker sets spanning the genome, large-scale mutagenesis screens of mod
el organisms, and genome-wide expression profiling have all begun to contri
bute to the identification of new genes and mechanisms that are central to
cardiovascular disease processes.